Aarskog D, Aksnes L, Markestad T, Rødland O
J Clin Endocrinol Metab. 1983 Dec;57(6):1155-8. doi: 10.1210/jcem-57-6-1155.
To determine the effect of estrogen on vitamin D metabolism in pubertal girls, we studied 16 tall girls treated with a daily dose of 4-8 mg estradiol valerate to curtail excessive adult height. In all but one girl the plasma concentration of 1,25-dihydroxyvitamin D (1,25-(OH)2D) increased to values significantly higher than the corresponding pretreatment value (P less than 0.0005). The ratio of 24,25-dihydroxyvitamin D (24,25-(OH)2D) to 25-hydroxyvitamin D decreased in all girls (P less than 0.0005). The vitamin D binding protein (DBP) also increased significantly after estrogen (P less than 0.025), and there was a significant positive correlation between the plasma concentration of 1,25-(OH)2D and DBP (r = 0.66; P less than 0.0005). The free fraction of 1,25-(OH)2D remained unchanged after estrogen. It appears that estrogen treatment increases the plasma concentration of 1,25-(OH)2D. The effect might be explained by the concomitant increase in DBP and/or by estrogen stimulation of renal 1 alpha-hydroxylase.
为了确定雌激素对青春期女孩维生素D代谢的影响,我们研究了16名身材高大的女孩,她们每日服用4 - 8毫克戊酸雌二醇以抑制成年后的过高身高。除一名女孩外,所有女孩的1,25 - 二羟基维生素D(1,25-(OH)2D)血浆浓度均升高至显著高于相应治疗前值的水平(P < 0.0005)。所有女孩的24,25 - 二羟基维生素D(24,25-(OH)2D)与25 - 羟基维生素D的比值均下降(P < 0.0005)。雌激素治疗后维生素D结合蛋白(DBP)也显著增加(P < 0.025),并且1,25-(OH)2D血浆浓度与DBP之间存在显著正相关(r = 0.66;P < 0.0005)。雌激素治疗后1,25-(OH)2D的游离部分保持不变。看来雌激素治疗会增加1,25-(OH)2D的血浆浓度。这种作用可能是由于DBP的同时增加和/或雌激素对肾脏1α - 羟化酶的刺激所致。